Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Update Il y a 5 ans
Reference: NCT00076011

Woman and Man

Extract

The primary purpose of this protocol is to determine the activity of AG 013736 in patients with metastatic renal cell cancer who have received 1 prior cytokine-based therapy.


Inclusion criteria

  • Kidney Neoplasms

Links